Logo image of BAM.CA

BROOKFIELD ASSET MGMT-A (BAM.CA) Stock Fundamental Analysis

TSX:BAM - Toronto Stock Exchange - CA1130041058 - Common Stock - Currency: CAD

75.83  -1.36 (-1.76%)

Fundamental Rating

5

Overall BAM gets a fundamental rating of 5 out of 10. We evaluated BAM against 82 industry peers in the Capital Markets industry. Both the profitability and the financial health of BAM get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, BAM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BAM was profitable.
In the past year BAM had a positive cash flow from operations.
Each year in the past 5 years BAM has been profitable.
BAM had a positive operating cash flow in 4 of the past 5 years.
BAM.CA Yearly Net Income VS EBIT VS OCF VS FCFBAM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

BAM's Return On Assets of 6.32% is fine compared to the rest of the industry. BAM outperforms 78.05% of its industry peers.
BAM has a better Return On Equity (9.08%) than 71.95% of its industry peers.
With a decent Return On Invested Capital value of 4.07%, BAM is doing good in the industry, outperforming 71.95% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BAM is significantly below the industry average of 7.96%.
The last Return On Invested Capital (4.07%) for BAM is above the 3 year average (1.27%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.32%
ROE 9.08%
ROIC 4.07%
ROA(3y)9%
ROA(5y)7.21%
ROE(3y)13.06%
ROE(5y)12.5%
ROIC(3y)1.27%
ROIC(5y)3.38%
BAM.CA Yearly ROA, ROE, ROICBAM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

BAM has a better Profit Margin (66.67%) than 84.15% of its industry peers.
In the last couple of years the Profit Margin of BAM has grown nicely.
BAM has a better Operating Margin (51.23%) than 80.49% of its industry peers.
In the last couple of years the Operating Margin of BAM has declined.
Industry RankSector Rank
OM 51.23%
PM (TTM) 66.67%
GM N/A
OM growth 3Y-30.79%
OM growth 5Y-18.69%
PM growth 3Y22.85%
PM growth 5Y4.98%
GM growth 3YN/A
GM growth 5YN/A
BAM.CA Yearly Profit, Operating, Gross MarginsBAM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80 100

6

2. Health

2.1 Basic Checks

The number of shares outstanding for BAM has been increased compared to 1 year ago.
The debt/assets ratio for BAM has been reduced compared to a year ago.
BAM.CA Yearly Shares OutstandingBAM.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
BAM.CA Yearly Total Debt VS Total AssetsBAM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 12.28 indicates that BAM is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 12.28, BAM belongs to the best of the industry, outperforming 85.37% of the companies in the same industry.
BAM has a debt to FCF ratio of 2.09. This is a good value and a sign of high solvency as BAM would need 2.09 years to pay back of all of its debts.
BAM has a Debt to FCF ratio of 2.09. This is in the better half of the industry: BAM outperforms 75.61% of its industry peers.
BAM has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.15, BAM is in the better half of the industry, outperforming 60.98% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.09
Altman-Z 12.28
ROIC/WACCN/A
WACCN/A
BAM.CA Yearly LT Debt VS Equity VS FCFBAM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

BAM has a Current Ratio of 1.37. This is a normal value and indicates that BAM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.37, BAM is in the better half of the industry, outperforming 62.20% of the companies in the same industry.
BAM has a Quick Ratio of 1.37. This is a normal value and indicates that BAM is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.37, BAM is doing good in the industry, outperforming 62.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
BAM.CA Yearly Current Assets VS Current LiabilitesBAM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

BAM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.76%, which is quite good.
The earnings per share for BAM have been decreasing by -22.95% on average. This is quite bad
The Revenue has grown by 264.78% in the past year. This is a very strong growth!
The Revenue for BAM have been decreasing by -26.01% on average. This is quite bad
EPS 1Y (TTM)11.76%
EPS 3Y-34.73%
EPS 5Y-22.95%
EPS Q2Q%21.21%
Revenue 1Y (TTM)264.78%
Revenue growth 3Y-46.15%
Revenue growth 5Y-26.01%
Sales Q2Q%-2.88%

3.2 Future

The Earnings Per Share is expected to grow by 15.88% on average over the next years. This is quite good.
The Revenue is expected to grow by 10.12% on average over the next years. This is quite good.
EPS Next Y14.59%
EPS Next 2Y15.46%
EPS Next 3Y15.88%
EPS Next 5YN/A
Revenue Next Year11.37%
Revenue Next 2Y12.57%
Revenue Next 3Y10.12%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BAM.CA Yearly Revenue VS EstimatesBAM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
BAM.CA Yearly EPS VS EstimatesBAM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 36.46 indicates a quite expensive valuation of BAM.
Based on the Price/Earnings ratio, BAM is valued a bit more expensive than 65.85% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.29, BAM is valued a bit more expensive.
With a Price/Forward Earnings ratio of 28.73, BAM can be considered very expensive at the moment.
BAM's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.74, BAM is valued a bit more expensive.
Industry RankSector Rank
PE 36.46
Fwd PE 28.73
BAM.CA Price Earnings VS Forward Price EarningsBAM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BAM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 122.2
EV/EBITDA N/A
BAM.CA Per share dataBAM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BAM may justify a higher PE ratio.
A more expensive valuation may be justified as BAM's earnings are expected to grow with 15.88% in the coming years.
PEG (NY)2.5
PEG (5Y)N/A
EPS Next 2Y15.46%
EPS Next 3Y15.88%

3

5. Dividend

5.1 Amount

BAM has a Yearly Dividend Yield of 2.25%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.39, BAM has a dividend in line with its industry peers.
BAM's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.25%

5.2 History

BAM has been paying a dividend for over 5 years, so it has already some track record.
BAM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
BAM.CA Yearly Dividends per shareBAM.CA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

125.58% of the earnings are spent on dividend by BAM. This is not a sustainable payout ratio.
DP125.58%
EPS Next 2Y15.46%
EPS Next 3Y15.88%
BAM.CA Yearly Income VS Free CF VS DividendBAM.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B
BAM.CA Dividend Payout.BAM.CA Dividend Payout, showing the Payout Ratio.BAM.CA Dividend Payout.PayoutRetained Earnings

BROOKFIELD ASSET MGMT-A

TSX:BAM (7/7/2025, 7:00:00 PM)

75.83

-1.36 (-1.76%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners17%
Inst Owner ChangeN/A
Ins Owners1.94%
Ins Owner ChangeN/A
Market Cap124.16B
Analysts68.57
Price Target80.54 (6.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.25%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP125.58%
Div Incr Years3
Div Non Decr Years3
Ex-Date05-30 2025-05-30 (0.4375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.17%
Min EPS beat(2)-1.13%
Max EPS beat(2)1.46%
EPS beat(4)2
Avg EPS beat(4)0.88%
Min EPS beat(4)-2.55%
Max EPS beat(4)5.74%
EPS beat(8)4
Avg EPS beat(8)1.73%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.41%
Min Revenue beat(2)-17.67%
Max Revenue beat(2)-17.15%
Revenue beat(4)0
Avg Revenue beat(4)-9.23%
Min Revenue beat(4)-17.67%
Max Revenue beat(4)-0.58%
Revenue beat(8)0
Avg Revenue beat(8)-8.6%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.08%
PT rev (3m)-6.9%
EPS NQ rev (1m)-0.07%
EPS NQ rev (3m)-1.41%
EPS NY rev (1m)0.15%
EPS NY rev (3m)-1.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.59%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-0.91%
Valuation
Industry RankSector Rank
PE 36.46
Fwd PE 28.73
P/S 64.07
P/FCF 122.2
P/OCF 121.71
P/B 8.73
P/tB 8.73
EV/EBITDA N/A
EPS(TTM)2.08
EY2.74%
EPS(NY)2.64
Fwd EY3.48%
FCF(TTM)0.62
FCFY0.82%
OCF(TTM)0.62
OCFY0.82%
SpS1.18
BVpS8.69
TBVpS8.69
PEG (NY)2.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.32%
ROE 9.08%
ROCE 6.09%
ROIC 4.07%
ROICexc 4.18%
ROICexgc 4.38%
OM 51.23%
PM (TTM) 66.67%
GM N/A
FCFM 52.43%
ROA(3y)9%
ROA(5y)7.21%
ROE(3y)13.06%
ROE(5y)12.5%
ROIC(3y)1.27%
ROIC(5y)3.38%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.93%
ROCE(5y)4.85%
ROICexcg growth 3Y-36.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y-36.35%
ROICexc growth 5YN/A
OM growth 3Y-30.79%
OM growth 5Y-18.69%
PM growth 3Y22.85%
PM growth 5Y4.98%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.09
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 31.61
Cash Conversion N/A
Profit Quality 78.65%
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 12.28
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)18.12%
Cap/Sales(5y)11.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.76%
EPS 3Y-34.73%
EPS 5Y-22.95%
EPS Q2Q%21.21%
EPS Next Y14.59%
EPS Next 2Y15.46%
EPS Next 3Y15.88%
EPS Next 5YN/A
Revenue 1Y (TTM)264.78%
Revenue growth 3Y-46.15%
Revenue growth 5Y-26.01%
Sales Q2Q%-2.88%
Revenue Next Year11.37%
Revenue Next 2Y12.57%
Revenue Next 3Y10.12%
Revenue Next 5YN/A
EBIT growth 1Y1072.58%
EBIT growth 3Y-62.73%
EBIT growth 5Y-39.83%
EBIT Next Year17.11%
EBIT Next 3Y17.48%
EBIT Next 5YN/A
FCF growth 1Y514.88%
FCF growth 3Y-25.34%
FCF growth 5Y-6.68%
OCF growth 1Y372.79%
OCF growth 3Y-24.26%
OCF growth 5Y-5.43%